• ქართული
  • English
  • Drugmaker Shire soars as Japan's Takeda considers bid

    LONDON/TOKYO (Reuters) – Japan’s largest drugmaker Takeda Pharmaceutical is considering a bid for London-listed Shire that could top $40 billion and spark another takeover battle in the deal-hungry pharma industry.

    Market Quotes by TradingView